We report our single center experience demonstrating that HLA Class I alloimmunization predicts longer time to platelet engraftment, increased bleeding complications and higher transfusion requirements in patients undergoing gene-modified hematopoietic stem cell transplant for transfusion-dependent beta thalassemia.

Subjects:
Gene Therapy
This content is only available as a PDF.
Copyright © 2025 American Society of Hematology
2025

Article PDF first page preview

Article PDF first page preview
You do not currently have access to this content.
Sign in via your Institution